A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Clinical trial NCT06227910 · RECRUITING

Trial details

NCT number: NCT06227910
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2025-01-02
Primary completion: 2027-06-08
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.